Literature DB >> 6873150

Effect of cholestyramine and colestipol on the absorption of phenytoin.

J T Callaghan, M Tsuru, J L Holtzman, D B Hunninghake.   

Abstract

The hypocholesterolemic cation resins, cholestyramine and colestipol, have variable effects on the absorption parameters of a number of lipophillic, anion drugs. Because of the unpredictable nature of this interaction, we have assessed in human volunteers the effect of these resins on the rate and total absorption of phenytoin. Our results indicate that these resins do not affect the absorption parameters of phenytoin and that special care does not have to be exercised when these agents are co-administered.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6873150     DOI: 10.1007/bf00542221

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  8 in total

1.  Digitalis intoxication. Treatment with a new steroid-binding resin.

Authors:  G Bazzano; G S Bazzano
Journal:  JAMA       Date:  1972-05-08       Impact factor: 56.272

2.  Quantitative estimation of diphenylhydantoin, primidone and phenobarbital in plasma by gas-liquid chromatography.

Authors:  H J Kupferberg
Journal:  Clin Chim Acta       Date:  1970-08       Impact factor: 3.786

3.  The influence of cholestyramine on thyroxine absorption.

Authors:  R C Northcutt; J N Stiel; J W Hollifield; E G Stant
Journal:  JAMA       Date:  1969-06-09       Impact factor: 56.272

4.  The interaction between cholestyramine and drugs.

Authors:  D G Gallo; K R Bailey; A L Sheffner
Journal:  Proc Soc Exp Biol Med       Date:  1965-10

5.  Decreased bioavailability of digoxin due to hypocholesterolemic interventions.

Authors:  D D Brown; R P Juhl; S L Warner
Journal:  Circulation       Date:  1978-07       Impact factor: 29.690

6.  ESTRIP, a BASIC computer program for obtaining initial polyexponential parameter estimates.

Authors:  R D Brown; J E Manno
Journal:  J Pharm Sci       Date:  1978-12       Impact factor: 3.534

7.  The effect of cholestyramine and colestipol on the absorption of hydrochlorothiazide.

Authors:  D B Hunninghake; S King; K LaCroix
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1982-04

8.  Interruption of the enterohepatic circulation of digitoxin by cholestyramine. II. Effect on metabolic disposition of tritium-labeled digitoxin and cardiac systolic intervals in man.

Authors:  J H Caldwell; C A Bush; N J Greenberger
Journal:  J Clin Invest       Date:  1971-12       Impact factor: 14.808

  8 in total
  5 in total

1.  The effect of cholestyramine and activated charcoal on glipizide absorption.

Authors:  K T Kivistö; P J Neuvonen
Journal:  Br J Clin Pharmacol       Date:  1990-11       Impact factor: 4.335

Review 2.  Pharmacokinetic drug interactions with phenytoin (Part II).

Authors:  R L Nation; A M Evans; R W Milne
Journal:  Clin Pharmacokinet       Date:  1990-02       Impact factor: 6.447

Review 3.  Drug interactions that matter. A critical reappraisal.

Authors:  G T McInnes; M J Brodie
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

4.  Effects of resins and activated charcoal on the absorption of digoxin, carbamazepine and frusemide.

Authors:  P J Neuvonen; K Kivistö; E L Hirvisalo
Journal:  Br J Clin Pharmacol       Date:  1988-02       Impact factor: 4.335

Review 5.  Colestipol: a review of its pharmacological properties and therapeutic efficacy in patients with hypercholesterolaemia.

Authors:  R C Heel; R N Brogden; G E Pakes; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-03       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.